By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel consensus is bearish on IBM, citing real execution shortfalls, software commoditization, and the risk of IBM's quantum and consulting segments being substituted by cloud platforms and AI-native competitors.
Risk: The inability to translate high-margin software growth into meaningful free cash flow expansion and the risk of consulting commoditization.
Opportunity: The potential for IBM's hybrid cloud and AI offerings to gain traction in the market and deliver promised synergies.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
We recently published Jim Cramer Discussed These 10 Stocks Including A Hidden Gem & An AI Short. International Business Machines Corporation (NYSE:IBM) is one of the stocks discussed by Jim Cramer.
International Business Machines Corporation (NYSE:IBM)’s shares have struggled recently as they are down by 1.9% over the past year and by 12.9% year-to-date. RBC Capital discussed the firm on May 7th as it cut the share price target to $300 from $330 and kept an Outperform rating. The bank remarked that its coverage came after International Business Machines Corporation (NYSE:IBM)’s IBM Think conference and added that its coverage reflected a compression in peer valuation multiples. The software and enterprise computing firm is one of Cramer’s top stocks. Throughout 2025, the CNBC TV host praised International Business Machines Corporation (NYSE:IBM) for its software business and its quantum computing efforts. So, naturally, he isn’t pleased with the recent share price performance:
“IBM is I think overdone because of the downside. people feel it doesn’t have the right, its quantum is not big enough to offset the software it has. You don’t need the consultants, because the stuff’s so easy. You know that. It’s the rap, that’s the Anthropic rap.”
While we acknowledge the potential of IBM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.** **
Disclosure: None. Follow Insider Monkey on Google News.
Four leading AI models discuss this article
"RBC's multiple compression call and pre-commercial quantum timeline point to sustained underperformance versus AI peers rather than a sentiment-driven bargain."
Cramer's claim that IBM's downside is 'overdone' ignores RBC's May 7 target cut to $300 amid peer multiple compression, signaling the market is pricing slower software growth against AI-native competitors. Quantum remains pre-revenue for years while mainframe and consulting face substitution risks from cloud platforms. The 12.9% YTD drop and 1.9% trailing-year decline track real execution shortfalls, not mere perception, especially as tariffs and onshoring themes favor other AI names the article itself flags as superior.
IBM's software recurring revenue could still deliver steady 5-7% growth that the market is under-appreciating, making the valuation reset temporary rather than structural.
"IBM's 12.9% YTD decline reflects valuation compression and sector rotation, not fundamental deterioration—but the case hinges entirely on whether Red Hat and hybrid cloud can sustain 15%+ EBITDA growth through 2026."
This article is mostly noise. Cramer's complaint—that IBM's quantum hype doesn't offset software commoditization—is real but not new. RBC's $330→$300 target cut (9% downside) reflects valuation compression, not fundamental deterioration. IBM trades ~22x forward P/E; if software margins hold and Red Hat integration delivers the promised $3.5B+ synergies by 2027, that multiple is defensible. The article's real tell: it dismisses IBM to promote an unnamed 'undervalued AI stock'—classic clickbait. YTD -12.9% is painful but reflects sector rotation, not IBM-specific failure. Missing: IBM's hybrid cloud TAM ($60B+), consulting's actual margin trajectory, and whether quantum remains a sideshow or becomes material by 2027.
If enterprise software commoditizes faster than expected and consulting demand collapses in a recession, IBM's legacy cost structure becomes a liability, not a moat. Cramer's 'overdone downside' framing could be recency bias masking real structural headwinds.
"IBM's valuation compression is not just a sentiment issue; it is a fundamental reflection of the market's skepticism toward the long-term profitability of their consulting-led AI integration strategy."
IBM is currently trapped in a valuation purgatory. While Cramer fixates on the 'Anthropic rap'—the fear that generative AI makes legacy consulting obsolete—the real issue is the company's persistent inability to translate high-margin software growth into meaningful free cash flow expansion. Trading at roughly 16x forward earnings, IBM is priced for stability, not the transformative AI growth narrative it claims to lead. The pivot to hybrid cloud and AI is structurally sound, but the consulting segment remains a drag on margins. Unless IBM can prove that its 'Consulting 2.0' model is immune to the commoditization of coding, the market will continue to compress its multiple relative to pure-play software peers.
If IBM successfully leverages its enterprise incumbency to become the primary 'AI orchestrator' for the Fortune 500, the current valuation ignores the massive recurring revenue potential of its Granite model stack.
"Near-term risk to IBM is that AI-driven software growth remains tepid and the market re-rates peers on cloud momentum, leaving IBM exposed to multiple compression even if longer-term catalysts exist."
IBM’s narrative hinges on a pivot to software and AI, but the piece glosses over near-term growth fragility and how quickly peers can re-rate on cloud and AI momentum. The RBC price-target cut (300 vs 330) signals a re-rating risk that IBM may struggle to sustain margin and revenue gains versus faster cloud players. Missing context includes IBM’s actual margin trajectory, free cash flow discipline, and the pace at which hybrid-cloud customers truly embrace IBM’s software stack and AI offerings. If AI demand slows or customer deals disappoint, the touted long-run catalysts may not offset immediate multiple compression.
Strong counterpoint: if IBM proves durable software revenue growth with meaningful margin expansion, the stock could re-rate faster than peers, making the cautious tone here overly pessimistic.
"Conflicting P/E figures between Gemini and Claude expose an unresolved valuation inconsistency that undercuts the stability pricing argument."
Gemini's 16x forward earnings clashes directly with Claude's 22x, creating an unresolved valuation gap that weakens the purgatory thesis. If the RBC cut already embeds peer compression, the hybrid-cloud TAM only offsets consulting commoditization if FCF actually accelerates beyond the stability already priced in. The overlooked linkage is whether Granite's recurring revenue can outpace mainframe substitution before 2027 synergies arrive.
"The valuation debate between 16x and 22x is a sideshow if enterprise customers fragment their AI tooling rather than consolidate on IBM's platform."
Grok's valuation gap observation is sharp, but it obscures the real issue: both 16x and 22x assume IBM executes flawlessly on Granite adoption and Red Hat synergies. Neither accounts for the risk that enterprise customers adopt best-of-breed AI (OpenAI, Anthropic APIs) rather than lock into IBM's stack. The FCF acceleration Grok flags depends on consulting margin holding—exactly what commoditization threatens. This isn't a valuation disagreement; it's an execution risk nobody's quantifying.
"IBM's consulting segment is a failing lead-gen tool for software that cannot sustain the company's valuation if mainframe revenues continue their inevitable decay."
Claude and Grok are missing the structural reality of IBM’s 'Consulting 2.0': it is a Trojan horse for software sales, not a standalone margin engine. Gemini’s 'purgatory' thesis is the most accurate because the market isn't pricing in AI growth; it’s pricing in a terminal decline of the mainframe. If Granite doesn't achieve high-margin software lock-in, the 16x multiple is actually a value trap, not a floor, regardless of Red Hat synergies.
"Granite's recurrence and potential margin expansion are front-loaded risks; without faster FCF growth and timely take-up, IBM's 16x floor is fragile, not a given."
To Grok: your focus on Granite as a pure recurrence lever ignores timing risk. Even if Red Hat synergies show, FCF expansion hinges on hardware/consulting cost discipline and real uptake of Granite before 2027—a long path in enterprise buying cycles. The article’s momentum risk isn’t just multiple compression; it’s whether IBM can convert pipeline into durable margins, not just stabilized earnings. Without faster FCF growth, the 16x floor remains fragile.
The panel consensus is bearish on IBM, citing real execution shortfalls, software commoditization, and the risk of IBM's quantum and consulting segments being substituted by cloud platforms and AI-native competitors.
The potential for IBM's hybrid cloud and AI offerings to gain traction in the market and deliver promised synergies.
The inability to translate high-margin software growth into meaningful free cash flow expansion and the risk of consulting commoditization.